Researcher
Olivier De Wever
- Keywords:tumor models, tumor environment
- Disciplines:Cancer diagnosis, Cancer therapy, Cancer biology
Affiliations
- Department of Human Structure and Repair (Department)
Member
From1 Oct 2018 → Today - Department of Radiation oncology and experimental cancer research (Department)
Member
From1 Oct 1999 → 30 Sep 2018
Projects
1 - 10 of 36
- Facility : Patiënt-afgeleide xenograft modellen – UGent;From1 Feb 2024 → TodayFunding: BOF - research organisations
- Clinical Tissue and Cell Culture coreFrom1 Feb 2024 → TodayFunding: BOF - research organisations
- Evaluating the potential of Multidrug Adjunctive Cancer Treatment (MDACT) in glioblastomaFrom1 Nov 2023 → TodayFunding: FWO Strategic Basic Research Grant
- Evaluation of cellular dynamics using automated widefield imagingFrom15 Dec 2022 → TodayFunding: BOF - scientific equipment program
- Tissue and cell culture core facilityFrom15 Dec 2022 → TodayFunding: BOF - scientific equipment program
- Single-cell ICP-mass spectrometry in the biological sciences: on the way to real-world useFrom1 Nov 2022 → 31 Dec 2022Funding: FWO senior postdoctoral fellowship
- Analyzing the immunobiological function of circulating bacterial extracellular vesicles in cancer patientsFrom1 Oct 2022 → 31 Oct 2023Funding: BOF - doctoral mandates
- A patient derived xenograft (PDX) platform for in vivo evaluation of novel anticancer therapiesFrom1 May 2022 → TodayFunding: FWO Medium Size Research Infrastructure
- White light laser-based confocal fluorescence lifetime imaging microscope for multi-parameter 3D live imagingFrom1 May 2022 → TodayFunding: FWO Medium Size Research Infrastructure
- Ultrafast-scanning tandem ICP-mass spectrometer for interference-free and highly-sensitive transient signal monitoringFrom1 May 2022 → TodayFunding: FWO Medium Size Research Infrastructure
Publications
21 - 30 of 77
- A systematic review on extracellular vesicles-enriched fat grafting : a shifting paradigm(2021)
Authors: Mohammad Ghiasloo, Laura De Wilde, Patrick Tonnard, Alexis Verpaele, Olivier De Wever, Phillip Blondeel
Pages: NP1695 - NP1705 - Patient-derived cell lines and xenografts from sarcoma patients as models for therapeutic decision making(2021)
Authors: Suzanne Fischer, David Creytens, Gwen Sys, Lore Lapeire, An Hendrix, Olivier De Wever
Number of pages: 1 - Substantial performance differences among RNA purification kits and blood collection tubes in the Extracellular RNA Quality Control (exRNAQC) study(2021)
Authors: Anneleen Decock, Olivier De Wever, Celine Everaert, Hetty Helsmoortel, An Hendrix, Pieter Mestdagh, Annelien Morlion, Jo Vandesompele, Ruben Van Paemel, Francisco Avila Cobos, et al.
Number of pages: 1 - Metastasis-suppressor NME1 controls the invasive switch of breast cancer by regulating MT1-MMP surface clearance(2021)
Authors: Catalina Lodillinsky, Laetitia Fuhrmann, Marie Irondelle, Olena Pylypenko, Xiao-Yan Li, Hélène Bonsang-Kitzis, Fabien Reyal, Sophie Vacher, Claire Calmel, Olivier De Wever, et al.
Pages: 4019 - 4032 - Unexpected effects of a selective and potent c-MET inhibitor in an immunocompetent intraductal model for triple-negative breast cancer(2021)
Authors: Jonas Steenbrugge, Niels Vander Elst, Kristel Demeyere, Olivier De Wever, Niek Sanders, Wim Van Den Broeck, Annegret Van der Aa, Eric Ciamporcero, Timothy Perera, Evelyne Meyer
Number of pages: 1 - Establishment and characterization of a cell line and patient-derived xenograft (PDX) from peritoneal metastasis of low-grade serous ovarian carcinoma(2020)
Authors: Elien De Thaye, Koen Van de Vijver, Joni Van der Meulen, Joachim Taminau, Glenn Wagemans, Hannelore Denys, Jo Van Dorpe, Geert Berx, Wim Ceelen, Jan Van Bocxlaer, et al.
- The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressiveness(2020)
Authors: Liselot Mus, Irina Lambertz, Shana Claeys, Candy Kumps, Wouter Van Loocke, Christophe Van Neste, Ganesh Umapathy, Marica Vaapil, Christoph Bartenhagen, Genevieve Laureys, et al.
- Substantial performance differences among RNA purification kits and blood collection tubes in the Extracellular RNA Quality Control study-important considerations for liquid biopsies(2020)Volume: 26
Authors: Anneleen Decock, Jasper Anckaert, Celine Everaert, Justine Nuytens, Scott Kuersten, An Hendrix, Jo Vandesompele, Pieter Mestdagh, Bert Dhondt, Ruben Van Paemel, et al.
Pages: 93 - 94 - Fructosamine-3-kinase as a potential treatment option for age-related macular degeneration(2020)
Authors: Sander De Bruyne, Caroline Van den Broecke, Henk Vrielinck, Samira Khelifi, Olivier De Wever, Ken Bracke, Manon Huizing, Nezahat Boston, Jonas Himpe, Marijn Speeckaert, et al.
- MIFlowCyt-EV : a framework for standardized reporting of extracellular vesicle flow cytometry experiments(2020)
Authors: Joshua A. Welsh, Edwin Van Der Pol, Ger J.A. Arkesteijn, Michel Bremer, Alain Brisson, Frank Coumans, Françoise Dignat-George, Erika Duggan, Ionita Ghiran, Bernd Giebel, et al.
Patents
1 - 5 of 5
- Use of bacterial extracellular vesicles as a biomarker for intestinal barrier permeability and microbial dysbiosis (Inventor)
- Targeting quorum-sensing peptides for diagnosis, treatment and/or prevention of colorectal cancer metastasis (Inventor)
- Use of bacterial extracellular vesicles as a biomarker for intestinal barrier permeability and microbial dysbiosis (Inventor)
- Usages of recombinant extracellular vesicles (Inventor)
- Usages of recombinant extracellular vesicles (Inventor)